Introduction
A precise diagnosis of neurosyphilis is usually difficult to establish but may be easier in patients with classical clinical symptoms as well as pathological findings in the cerebrospinal fluid (CSF) . The presence of pleocytosis, raised protein concentrations (Dattner- Of the assays using Treponema pallidum as antigen,9 the CSF fluorescent treponemal antibodyabsorption (FTA-ABS) test seems to be a very sensitive method. Non-reactivity in this test apparently excludes neurosyphilis.'0 A reactive FTA-ABS result, however, is not a reliable indicator of active disease since reactivity may be caused by transudation of immunoglobulins from the serum into the CSF. 10 Immunoglobulins of the IgG class directed against Tpallidum can often be found in the serum as well as in the CSF many years after adeqv.ate treatment. '2 The Tpallidum haemagglutination assay (TPHA) and its microversion, the automated microhaemagglutination assay using Tpallidum antigen (AMHA- The TPHA index relates the TPHA titre to the albumin quotient and thereby attempts to exclude errors from disturbed function of the blood-brain barrier. TPHA indices of patients with active neurosyphilis were above 500 in 10 of 13 cases, while those of patients who had been effectively treated two years before examination were all below 100 (except for patients 8 and 11) (figure).
Results of tests for T pallidum-specific IgA antibodies are described elsewhere.38 
Discussion
The diagnosis of neurosyphilis may be suspected but cannot be based on clinical symptoms alone; this, as well as the occurrence of atypical oligosymptomatic forms, often presents the physician with the dilemma The present study indicated that only six (46%) of 13 patients with active neurosyphilis had >10 x 106 cells/l (10/mm3). On the other hand, five (21 -7 %) of 23 patients with latent syphilis who had no CNS signs or had been adequately treated for neurosyphilis more than two years previously and had reactive results in the CSF-TPHA test had >10 x 106 cells/I (10/mm3) and eight (34-8Gb) of 23 had total protein concentrations above 0 5 g/l (50 mg/100 ml).
The CSF-VDRL test was non-reactive in five (38 5 %) of 13 patients with active neurosyphilis and these results are in agreement with the findings of other workers.3 411 The CSF-FTA and CSF-TPHA test results were both reactive in all patients with active neurosyphilis. Thus a non-reactive CSF-TPHA or CSF-FTA test result or both apparently excludes active neurosyphilis.
The detection of 19S-IgM antibodies specific for T pallidum in the serum depends on the presence of antigen and consequently indicates the need for treatment.38-43 All patients with untreated active neurosyphilis showed specific 19S-IgM antibodies in the serum and in the CSF by the SPHA technique, except for patient 5 who, surprisingly, had a nonreactive result to this assay in both the serum and the CSF. This patient had been inadequately treated with 800 000 IU clemizol penicillin (which is equivalent to approximately 600 000 IU of procaine penicillin) twice daily for seven days eight months before examination. This seems to suggest that even subcurative doses of penicillin may abolish reactivity in the CSF-19S-IgM-SPHA test. 19S-IgM antibodies could be detected by the fluorescent technique in only three of 11 The TPHA index relates the function of the bloodbrain barrier to Tpallidum-specific antibodies. 10 The individual TPHA indices of the patients in the present study are shown in the figure. All samples, except one, from patients with active neurosyphilis had TPHA indices above 100. The indices of the patients who had been adequately treated more than two years before examination were below 100 (except in the case of patients 8 and 11). Both had been treated three years before examination, one (No 8) with 1 -2 million units procaine penicillin for 10 
